The scale of the underlying problem is sobering. According to the World Health Organization, cancer is the second leading cause of death globally, with roughly 20 million new cases diagnosed in 2022, a figure expected to climb in the coming years. Pediatric cancers, though representing about one percent of global diagnoses, are also rising, with an estimated 13.7 million new cases of childhood cancer projected between 2020 and 2050. Each of those diagnoses ripples outward to parents, siblings, partners, and friends, many of whom take on informal caregiving roles with little psychological support of their own.

Receiving a potentially life-threatening diagnosis can trigger significant psychological and cognitive challenges that touch nearly every domain of personal life. If left unaddressed, this burden can erode well-being and quality of life, and can even undermine adherence to treatment itself. Psychological distress shapes how clearly patients think, how confident they feel in managing their illness, how they communicate with clinicians, how they perceive risk, and ultimately how they make some of the most consequential decisions of their lives. In other words, mental health is not a luxury add-on to cancer care; it is woven into the machinery of treatment outcomes.

Psycho-oncological interventions, when they are available, can support people of all ages, foster adherence to clinical recommendations, and help surface patients’ preferences and needs throughout the care pathway. Clinical practice guidelines already recommend psychological assessment not only at diagnosis but at multiple phases of the illness, because emotional and cognitive burden shifts over time and varies with psychological factors and age. The problem is delivery. Access to psycho-oncological support is limited across healthcare systems for structural reasons, including resource constraints and the insufficient integration of psychological care into routine oncological pathways. Individual-level barriers compound the problem: low awareness of available services, stigma, shame, perceived discrimination, and wide heterogeneity in patients’ perceived needs and help-seeking attitudes.

There is also a blind spot in the guidelines themselves. Most clinical practice guidelines focus primarily on adult populations, with comparatively limited attention to pediatric patients and informal caregivers, precisely the groups whose psychological needs can be most easily overlooked. It is against this backdrop that the ALTHEA project, whose full name expands to tAckling menTal Health cancer patients and their families: digital solutions for bEtter cAre, has taken shape. Co-funded by the European Union’s EU4Health Programme under grant agreement number 101161236, the project brings together an unusually broad coalition: oncologists, health psychologists, neuropsychologists, pediatric cancer specialists, nursing scientists, computer scientists, patient advocacy organizations, and European cancer policy bodies spanning countries from Italy and Germany to Ukraine, Lithuania, Cyprus, and beyond.

The centerpiece of the project is a novel web-based digital platform designed to serve both cancer patients and their informal caregivers across different stages of the care pathway, and to be available to healthcare professionals as well. The platform’s architecture rests on three integrated functions. The first is psychological and cognitive assessment: a unique testing battery will be developed for both pediatric and adult patients and informal caregivers, drawing on clinical practice guidelines, care guidelines, and existing validated tests and self-reported measures. The second function is support profile identification, and the third is the delivery of tailored psychological support and educational material, including resources that equip healthcare professionals to navigate mental health issues in oncology and to refer patients to specialized psycho-oncologists and neuropsychologists when needed.

The support profile system is where the platform’s technical ambition becomes most visible. Based on the results of the psychological and cognitive assessments, and taking into account what the consortium calls complexity indicators, psychosocial vulnerability factors that sharpen the specificity of the final classification, each user is assigned to one of four profiles corresponding to progressively higher levels of intervention intensity. Profile 0 users are invited to follow-up and ongoing reassessment through the screening module, so that early changes in psychosocial status can be detected. Profile 1 users receive general educational materials, self-help content, and digital interventions designed to support psychological adjustment and promote adaptive coping strategies, alongside continued reassessment. Profile 2 users receive self-help content, tailored educational materials, digital interventions, and guided professional support delivered through the platform by psycho-oncologists, health psychologists, and neuropsychologists, targeting issues such as emotional distress, sleep quality, and cognitive functioning in line with clinical best practice. Profile 3 users, those with the most complex needs, are referred to specialized care with personalized recommendations for integrated support, ensuring timely access to appropriate specialists.

What distinguishes ALTHEA from existing digital health platforms, its developers argue, is the combination of screening, classification into support profiles, and tailored interventions within a single platform, together with a co-creation approach that actively involves patients, caregivers, and healthcare professionals in its design. The development process will be grounded in the scientific literature and in data collected directly from end-users, an attempt to ensure the platform reflects real needs rather than assumptions about them. The consortium is also explicit about the risks. Digital solutions can overcome traditional barriers to access, but they can also generate new forms of inequality, for instance through uneven accessibility among countries. Some people, particularly older adults with lower levels of digital literacy, may be less inclined to engage with an online platform at all, and building a tool for heterogeneous populations requires the inclusion of a wide range of participant groups throughout the process to ensure the validity of its contents.

To counteract these risks, the authors outline a set of design and implementation strategies: inclusive design, multilingual interfaces, culturally adapted content, and careful prioritization of resources. Features such as gamification, easily accessible content, and low-bandwidth solutions may further enhance the platform’s ability to deliver tailored interventions and sustain user engagement across diverse populations. Crucially, the project treats people with lived experience of cancer not merely as study participants but as co-creators and advisors, an approach the consortium says enhances the platform’s relevance, usability, acceptability, and ethical foundation. Algorithm-based approaches to matching patients with support levels are described as promising, though the authors are candid that further empirical validation is needed to establish their effectiveness and generalisability.

If it delivers on its promise, the consortium argues, ALTHEA could contribute to more accessible and integrated psycho-oncological care by easing the incorporation of psychological support into routine clinical pathways, supporting early identification of psychological needs through structured screening, and improving access to tailored interventions across diverse populations. It may also inform more standardized approaches to mental health assessment in oncology and help build more equitable, scalable models of care. For now, the team is careful about what remains to be proven: future research will be essential to evaluate the platform’s clinical effectiveness, scalability, implementation in real-world settings, and its impact on clinical outcomes. But in a field where millions of patients and families navigate cancer’s psychological toll with inadequate support, the ambition of a single platform that screens, classifies, and responds to mental health needs across the entire cancer journey represents a significant step toward making the mind an equal partner with the body in cancer care.

Subject of Research: A digital mental health platform for cancer patients and their families

Article Title: Digital solutions for tackling mental health in cancer patients and their families: The ALTHEA project

Article References: Durosini, I., Monzani, D., Coppini, V., Ferrari, M. V., Bovolenta, C., Grigis, A., Curigliano, G., Zagami, P., Munzone, E., Minchella, I., Magnoni, F., Peccatori, F. A., Scholl, I., Meyerheim, M., Van Hemelrijck, M., Gsell, H., Gosak, L., Ciria-Suarez, L., Làvo, K., … the ALTHEA Consortium (2026). Digital solutions for tackling mental health in cancer patients and their families: The ALTHEA project. PLOS Digital Health, 5(10), e0001675. https://doi.org/10.1371/journal.pdig.0001675

Image Credits: AI Generated

DOI: 10.1371/journal.pdig.0001675

Keywords: digital health, psycho-oncology, cancer care, mental health screening, caregivers, ALTHEA project, EU4Health, clinical guidelines, patient empowerment, co-creation, telemedicine, healthcare inequality

The study, led by researchers at Tabriz University of Medical Sciences, set out to answer a question that has lingered in the chronic disease literature for years: does patient empowerment improve medication adherence directly, or does it work through an intermediate psychological mechanism? Drawing on Social Cognitive Theory, the team hypothesized that cardiac self-efficacy — a patient’s specific confidence in their ability to manage their heart condition, from controlling symptoms to maintaining daily function — serves as the essential bridge between feeling empowered and actually adhering to a medication regimen. The distinction matters enormously for clinical practice, because the two explanations call for very different interventions.

To test the model, the researchers recruited adults with confirmed coronary artery disease attending routine follow-up appointments, excluding anyone who had experienced an acute cardiac event within the previous 30 days. Participants completed three validated instruments: the 25-item Coronary Artery Disease Empowerment Scale, which measures self-determination, emotional self-regulation and personal competence; Sullivan’s 13-item Cardiac Self-Efficacy Scale, covering symptom control and maintaining function; and the widely used 8-item Morisky Medication Adherence Scale. All scales demonstrated good to excellent internal consistency in this sample, with Cronbach’s alpha values ranging from 0.75 to 0.92. The final sample of 266 complete responses exceeded the minimum of 259 participants required by an a priori power analysis.

The participants, whose mean age was 53.56 years and a slight majority of whom were women, were taking an average of just over four cardiovascular medications daily, most commonly antiplatelets, lipid-lowering agents and antihypertensives. Their average adherence score fell in the medium range, a pattern familiar to clinicians everywhere. On average, patients reported a total empowerment score of 97.71 out of a possible 125 and a cardiac self-efficacy score of 50.12 out of 65. Spearman’s correlations confirmed that all three key variables moved together: empowerment, self-efficacy and adherence were each positively and significantly associated with the others, with the strongest link appearing between self-efficacy and adherence.

The statistical heart of the study was a path analysis that modelled the three empowerment sub-dimensions as predictors of the two self-efficacy sub-dimensions, which in turn predicted medication adherence. The model fit the data remarkably well, with a chi-square to degrees of freedom ratio of 1.354, a Comparative Fit Index of 0.998 and a root mean square error of approximation of 0.037 — figures that comfortably exceed conventional thresholds for an excellent-fitting model. Because medication adherence is an ordinal measure, the team also ran a Bayesian estimation using Markov Chain Monte Carlo methods as a sensitivity check; the results were highly comparable, and convergence diagnostics confirmed the stability of the estimates.

The findings were striking in their specificity. Self-determination — the sense of autonomy and personal choice in managing one’s illness — emerged as the strongest predictor of both self-efficacy components, with standardized coefficients of 0.25 for symptom control and 0.33 for maintaining function. Emotional self-regulation also contributed significantly to maintaining function. But the personal competence sub-dimension, which captures knowledge and skills, failed to predict either component of self-efficacy. In other words, simply knowing what to do and how to do it did not build the confidence needed to do it. Bootstrap analysis with 1000 resamples confirmed that the indirect effects of self-determination and emotional self-regulation on adherence, transmitted through self-efficacy, were statistically significant, while the indirect effect of personal competence was not.

Perhaps the most consequential result came from the ordinal logistic regression. When both empowerment and self-efficacy were entered as predictors of adherence, self-efficacy remained a powerful and significant predictor — each one-unit increase in self-efficacy score was associated with a 9 percent increase in the odds of belonging to a higher adherence category — while total empowerment lost its significance entirely. The pattern suggests that the apparent relationship between empowerment and adherence reported in earlier studies may have been an artefact of failing to model self-efficacy simultaneously. Empowerment, in this model, does not act on behaviour directly; it acts by building the belief that action is possible.

This finding carries real theoretical weight. It lends empirical support to a long-standing critique in the empowerment literature, articulated by scholars such as Halvorsen and colleagues, that empowerment is too often reduced to a paternalistic process of transferring knowledge and skills. The Iranian data suggest exactly the opposite: the dimension associated with a genuine redistribution of power — self-determination — was the one that built self-efficacy, while the dimension resembling conventional patient education did not. The result also aligns neatly with Self-Determination Theory, which holds that supporting autonomy is the key to internalising motivation. Notably, the study found a much stronger correlation between empowerment and cardiac-specific self-efficacy than earlier work had found with general self-efficacy, underscoring the value of disease-specific measurement.

The clinical implications are direct. If self-efficacy is the bridge that empowerment must cross to become behaviour, then counselling strategies built purely on information delivery are unlikely to move the needle on adherence. Instead, the authors argue, nurses and other clinicians should deploy techniques that strengthen patients’ sense of autonomy — motivational interviewing, collaborative goal-setting and individualised self-management support. Empowerment-based interventions tested in randomized trials, from haemodialysis units to liver transplant programmes, have already shown that they can raise self-efficacy; this new path model helps explain why they work and which ingredients matter most.

The researchers are careful to acknowledge the limits of their design. The cross-sectional data cannot establish causal direction — successful adherence may itself reinforce self-efficacy over time — and all measures were self-reported, without objective pill counts, pharmacy refill records or clinical biomarkers. The convenience sample from a single referral clinic may not generalise widely, and unmeasured factors such as depression or health literacy could partly explain the observed pathways. Still, the study offers something the field has lacked: an empirically validated, ordered pathway from autonomy to confidence to action, tested in a Middle Eastern population where such models have rarely been examined. Future longitudinal and interventional studies, ideally with objective adherence measures and cross-cultural samples, will be needed to confirm the pathway. For now, the message to cardiology is clear: to get patients to take their pills, stop telling them what to do and start helping them believe they can.

Subject of Research: The mediating role of cardiac self-efficacy in the relationship between patient empowerment and medication adherence in coronary artery disease patients

Article Title: Cardiac Self‐Efficacy Mediates the Relationship Between Patient Empowerment and Medication Adherence: A Path Analysis in Patients With Coronary Artery Disease ‐ Empirical Research Quantitative

Article References: Allahbakhshian, A., Hashempour, F., Saiyadani, S., Sarbakhsh, P., Mohammadnezhad, M., & Radimaher, F. (2026). Cardiac Self‐Efficacy Mediates the Relationship Between Patient Empowerment and Medication Adherence: A Path Analysis in Patients With Coronary Artery Disease ‐ Empirical Research Quantitative. Nursing Open, 13(10), Article e70837. https://doi.org/10.1002/nop2.70837

Image Credits: AI Generated

DOI: 10.1002/nop2.70837

Keywords: coronary artery disease, medication adherence, patient empowerment, cardiac self-efficacy, path analysis, Social Cognitive Theory, self-determination, nursing, patient education, motivational interviewing, chronic disease self-management, Iran

The research team, led by Walaa Nady Sayed Kamel of Beni-Suef University together with colleagues from Tanta University and Kafrelsheikh University, recruited seventy adults with newly implanted permanent pacemakers at Tanta University Hospitals between December 2025 and April 2026. The study was grounded in two well-established theoretical frameworks: Bandura’s self-efficacy theory, which holds that people are more likely to perform health behaviours when they believe they are capable of doing so, and a patient-empowerment model that positions patients as active partners in their own care rather than passive recipients of instructions. This theoretical grounding mattered in practice, because the intervention was designed not simply to deliver information but to build confidence through repeated, hands-on mastery experiences, the mechanism that Bandura identified as the most powerful driver of self-efficacy.

The design was a non-equivalent control-group, pretest-posttest quasi-experiment, reported in accordance with the TREND statement for non-randomised evaluations. Thirty-five participants received routine hospital care alone, while a further thirty-five received that same routine care plus the structured empowerment protocol. Because the two arms were recruited in consecutive calendar periods rather than randomised concurrently, a strategy the authors used to prevent educational contamination between groups, group membership was confounded with time period, a limitation the researchers acknowledge explicitly. The protocol itself consisted of four individual sessions lasting thirty to forty-five minutes each, delivered by nurses using illustrated Arabic booklets, live demonstrations, and return demonstrations in which patients performed each skill themselves until competence was achieved. After the sessions, participants received weekly telephone reinforcement calls during the first month, a component designed to consolidate learning and address emerging questions before they hardened into unsafe habits.

The researchers measured three co-primary outcomes at baseline, immediately after the intervention, and at one-month follow-up. Knowledge was assessed with the Pacemaker-Related Knowledge Questionnaire, scored from zero to twenty. Practical competence was evaluated with an Observational Checklist scored from zero to fifty, in which trained assessors watched patients perform device-related self-care tasks. Self-care behaviour was measured with the Self-Care Behaviours Scale, scored from zero to twenty. Because three primary comparisons were tested, the team applied a family-wise significance threshold of 0.017, obtained by dividing the conventional 0.05 level by three, a conservative Bonferroni-style correction that reduces the risk of false-positive findings when multiple hypotheses are examined simultaneously.

The results were striking across all three domains. Mean knowledge scores in the intervention group rose from 6.51 at baseline to 15.31 immediately after the protocol, while the control group improved only from 5.57 to 7.46. The group-by-time interaction, tested with repeated-measures analysis of variance and the Greenhouse-Geisser correction for deviations from sphericity, yielded an F statistic of 148.09 with a p value below 0.001 and a partial eta squared of 0.685, meaning that roughly two-thirds of the variance in knowledge change over time was attributable to the intervention. The between-group difference after the intervention was 7.85 points, with a 95 percent confidence interval of 5.67 to 10.03 and a Cohen’s d of 1.69, an effect size conventionally classified as very large.

Practical competence showed an even more dramatic transformation. Intervention participants improved from a mean of 16.29 on the fifty-point observational checklist to 41.17, whereas control participants moved only from 14.91 to 18.54. The interaction effect was again highly significant, with F of 120.34, p below 0.001, and partial eta squared of 0.639. The post-intervention between-group difference of 22.63 points, with a confidence interval of 17.40 to 27.86 and a Cohen’s d of 2.03, represents an exceptionally large effect, one that exceeds the thresholds typically associated with clinically meaningful change by a wide margin. Self-care behaviour scores, measured on the twenty-point scale, climbed from 13.63 to 19.00 in the intervention group against a rise from 12.86 to 15.00 in controls, producing a difference of 4.00 points, a confidence interval of 2.52 to 5.48, and a Cohen’s d of 1.26. All three interactions remained significant at the corrected family-wise threshold, and importantly, the groups did not differ significantly on any recorded baseline characteristic, strengthening the argument that the observed differences stemmed from the intervention rather than pre-existing disparities.

The gains were partially sustained at the one-month follow-up, a detail with real clinical significance. Educational interventions in cardiac care frequently produce immediate improvements that evaporate once active teaching stops, a phenomenon known as the decay effect. The persistence of benefit here, even if incomplete, suggests that the weekly telephone reinforcement during the first month may have served as an effective maintenance mechanism, giving patients opportunities to rehearse knowledge and skills in their home environment while support was still available. This finding aligns with a broader trend in health-services research toward designing interventions with built-in booster components rather than relying on single episodes of education delivered at discharge, a moment when patients are often anxious, fatigued, and cognitively overloaded by the experience of recent surgery.

The authors are careful about what their design can and cannot prove. Because allocation was non-random and confounded with calendar period, and because outcome assessment was unblinded, the findings are best interpreted as an association observed under a quasi-experimental framework rather than causal evidence equivalent to that of a randomised controlled trial. Unblinded assessment, in particular, raises the possibility of measurement bias, since assessors aware of group assignment could unconsciously score the intervention group more generously. Secular changes between recruitment periods, such as shifts in staffing or seasonal differences in patient mix, represent an additional although less likely threat, given that the two periods spanned only a few months and baseline characteristics were well matched. The study was retrospectively registered on ClinicalTrials.gov under identifier NCT07743346, and the researchers received no external funding for the work.

Even with these caveats, the study carries substantial practical weight, particularly for low- and middle-income countries where robust evidence on structured post-implantation education has been scarce. The intervention required no expensive technology, no new devices, and no specialist physicians; it relied on nurses, printed booklets in patients’ own language, demonstrations, and phone calls, making it highly scalable in resource-constrained health systems. The effect sizes observed, with Cohen’s d values ranging from 1.26 to 2.03, are far larger than those typically reported for educational interventions in chronic disease management, where values above 0.8 are already considered large. If replicated under randomised, attention-controlled conditions with blinded assessment and longer follow-up, a protocol of this kind could reshape standard post-implantation nursing care, turning the weeks after pacemaker implantation from a period of anxious uncertainty into one of genuine patient empowerment. For now, the message from Tanta is clear and compelling: when nurses are given the structure and time to teach properly, patients learn, and what they learn may protect the device that keeps their hearts beating on schedule.

Subject of Research: Effect of a nurse-led empowerment protocol on knowledge, skills, and self-care in permanent pacemaker patients

Article Title: Effect of a structured nurse-led empowerment protocol on knowledge, practical skills, and self-care behaviours among patients with permanent pacemakers: a quasi-experimental study

Article References: Kamel, W. N. S., Assaf, A. R. A., Shehata, A. M., & Afify, N. M. M. (2026). Effect of a structured nurse-led empowerment protocol on knowledge, practical skills, and self-care behaviours among patients with permanent pacemakers: a quasi-experimental study. BMC Nursing, 25(1), Article 917. https://doi.org/10.1186/s12912-026-05368-3

Image Credits: AI Generated

DOI: 10.1186/s12912-026-05368-3

Keywords: permanent pacemaker, nurse-led intervention, patient empowerment, self-efficacy, self-care behaviours, quasi-experimental study, nursing education, cardiac care, patient knowledge, Egypt, BMC Nursing, post-implantation care

The survey of 1,008 Americans found that nearly two-thirds utilize some form of device to keep tabs on their cardiovascular wellbeing. The most commonly used devices include smartwatches, portable blood pressure monitors, fitness applications, and wearable fitness trackers. Interestingly, a mere 25% of these users leverage their device data in discussions with their doctors. This poses a critical question: why are patients not sharing this readily available information with their healthcare providers? This lack of communication could undermine the potential benefits of these devices, which are designed to facilitate early detection and proactive management of heart-related issues.

Dr. Laxmi Mehta, the director of Preventative Cardiology at The Ohio State University Wexner Medical Center, emphasizes the importance of patient engagement in their own health monitoring. According to Mehta, self-monitoring devices serve as invaluable tools for both patients and healthcare providers. For instance, if a patient notices persistent changes in their blood pressure, it may prompt them to seek medical advice sooner than they would during routine check-ups. Moreover, irregular heart rhythms, such as atrial fibrillation, can be identified early through these devices, significantly improving patient care.

Many patients, including 78-year-old Sue VanWassenhove, are increasingly inquiring about the advantages and disadvantages of these health monitors. After experiencing falls, VanWassenhove’s children gifted her a smartwatch to help track her health metrics. Living with sleep apnea, which affects her heart rate, she pays close attention to the data her device provides. When her smartwatch indicated a concerning pattern of heart rate abnormalities, she reached out to Dr. Mehta for further evaluation. This scenario highlights the vital role that personal monitoring can play in motivating individuals to take charge of their health.

Understanding the variability of heart rates is crucial for patients utilizing health monitors. Normal resting heart rates typically range from 60 to 100 beats per minute, but factors unrelated to heart health, such as infections, dehydration, anxiety, and thyroid disorders can also influence these numbers. As Mehta articulates, anytime a patient observes deviations from their usual heart rate or rhythm, they should consult their physician for further investigation. This understanding of one’s own health can stimulate productive dialogues between patients and doctors, leading to more comprehensive care.

In conjunction with a patient’s regular health routine, incorporating physical exercise is essential for cardiovascular health. Mehta notes that a simple formula to estimate an individual’s maximum heart rate is to subtract their age from 220. During moderate-intensity workouts, aiming for 50-75% of this maximum heart rate is recommended, while for vigorous activities, the target is 70-85%. Aligning exercise with these parameters is vital for maintaining an active and healthy heart.

During her consultation with Dr. Mehta, VanWassenhove discovered that her smartwatch had the capacity to perform electrocardiograms (ECGs), a procedure that records the heart’s electrical activity. The capability to send this data directly to her healthcare provider via an electronic medical record system signifies a noteworthy advancement in patient engagement and healthcare delivery. This use of technology allows patients to play an active role in managing their health, reinforcing the patient-doctor relationship.

While the advantages of self-monitoring devices are undeniable, the onus falls on both patients and physicians to enhance their collaboration in health management. Doctors need to encourage open dialogue regarding digital health records accumulated by personal devices, thereby prompting patients to share crucial information. By doing so, patients can play an active role in their health journey, using their health data affectionately and responsibly.

Moreover, healthcare providers should be educated about the functionalities of these devices to better understand how to integrate them into patient care plans effectively. Increased awareness among professionals will empower them to advise patients better on how to utilize their health data proactively. This sharing of information can ultimately lead to early interventions that not only save lives but significantly improve quality of life for those grappling with chronic health conditions.

Equally important is the need for healthcare systems to adapt to this new reality. Integrating self-monitoring data into electronic health record systems can streamline the process for healthcare providers, thereby enriching patient care. As digital health continues to evolve, the healthcare system must embrace these changes, ensuring that both patients and professionals can benefit from the technology available at their fingertips.

As we move forward, the convergence of technology in healthcare presents a wealth of possibilities. The patient’s perspective is gradually evolving toward an empowered model where individuals take responsibility for their health through various monitoring devices. However, the responsibility of healthcare providers remains to ensure that these empowered patients have the necessary support and guidance to use their devices effectively, ensuring that the information collected leads to actionable health decisions and improved patient outcomes.

The survey conducted by The Ohio State University Wexner Medical Center illuminates a crucial need in today’s healthcare landscape. Bridging the gap between patient data collection and the clinical insights that arise from it is imperative for enhancing cardiovascular health management. The synergy of technology, patient engagement, and healthcare provider collaboration will dictate the future of heart health monitoring and management.

This pivotal moment in health technology serves as a reminder that while innovation creates opportunities, open communication and understanding remain essential to translating that innovation into tangible health benefits. Engaging patients in their health journey can foster a culture in which proactive measures are taken, ultimately leading to healthier populations and a more efficient healthcare system.

—
Subject of Research: Heart Health Monitoring
Article Title: Bridging the Gap: Empowering Heart Health Through Technology
News Publication Date: January 22, 2024
Web References: N/A
References: N/A
Image Credits: The Ohio State University Wexner Medical Center
Keywords: Heart Health, Self-Monitoring Devices, Patient Engagement, Technology in Healthcare, Cardiovascular Health.